Infusion and injection billing in neurology is governed by the CPT drug administration code family, 96360 through 96379, which assigns every service a place in a strict hierarchy of initial, sequential, and concurrent codes based on route and time. Migraine therapies, multiple sclerosis biologics, IVIG for neuromuscular disease, and routine therapeutic injections all bill from this one family, and it has one of the most rigid structures in the entire CPT manual.
Neurology practices administer many infusions.
Migraine therapies, multiple sclerosis treatments, neuromuscular disease infusions, and various therapeutic injections all fall under the same core CPT code family.
The series ranges from 96360 through 96379, and this family has one of the most rigid hierarchical structures in the entire CPT manual.
Get the hierarchy wrong, and you’re not just risking a denial on one line item; you’re risking the whole claim getting reprocessed incorrectly.
By 2026, infusion-related billing errors are projected to account for more than 12 percent of outpatient claim rejections.
As a result, neurology practices bear more than their share of that risk, given how often infusion therapy is used in the treatment of chronic neurological disease.
This guide breaks down how the 96365 series works, how the initial-versus-additional hierarchy functions, and where neurology-specific billing traps tend to hide.
The Core Infusion and Injection Codes
The drug administration code family separates services into three basic delivery methods: infusion, IV push, and injection.
Each has its own time rules and its own place in the billing hierarchy, and mixing them up is one of the most common and costly mistakes in this part of neurology billing.
CPT 96365 and 96366: The Infusion Codes
CPT 96365 covers the initial intravenous infusion of a therapeutic, prophylactic, or diagnostic substance, for up to one hour.
The infusion needs to run for more than 15 minutes to qualify as an infusion rather than a push, and it needs to be documented with clear start and stop times in the medical record.
Once the infusion exceeds the one-hour mark by more than 30 minutes, you add a unit of add-on code 96366 for each additional qualifying period.
The thirty-minute threshold matters a lot here.
A single drug infused for exactly ninety minutes bills 96365 alone, no additional unit, because thirty minutes only meets the threshold rather than exceeding it.
Push that same infusion to ninety-one minutes or more, and you can now add one unit of 96366.
This rule catches a surprising number of billing teams off guard, since the difference between ninety and ninety-one minutes translates directly into whether a second billable unit exists at all.
CPT 96367 and 96368: Sequential and Concurrent Infusions
When a second, different drug is infused after the first one finishes, through the same IV access, that’s a sequential infusion, billed with add-on code 96367.
The documentation needs to show the stop time of the first drug and the start time of the second, making clear that one truly ended before the other began.
When two drugs run at the same time through the same IV access, that’s concurrent infusion, billed with add-on code 96368.
This code isn’t time-based, and Medicare guidance is clear that it’s reported only once per encounter, regardless of how many drugs are actually running concurrently or for how long. Concurrent hydration doesn’t fall under this code, since 96368 specifically applies to drugs, not to fluids given solely for hydration.
CPT 96372 and 96374: Injection and IV Push
CPT 96372 covers a therapeutic, prophylactic, or diagnostic injection given subcutaneously or intramuscularly.
This code is used constantly in neurology for things like non-antineoplastic hormonal therapy or other injectable medications that don’t require IV administration.
One detail worth knowing: this code generally shouldn’t be reported by a physician’s office when the physician isn’t present, though hospital settings have different rules.
CPT 96374 covers an intravenous push, defined as a bolus administration of fifteen minutes or less that requires staff to remain at the bedside throughout the administration.
When a push and a longer infusion both happen during the same encounter for different drugs, the infusion code, not the push code, becomes the initial service, based on the hierarchy rules covered next.
The Hierarchy Rule: Only One Initial Code Per Encounter
This is the single most important concept in infusion and injection billing, and it’s also the rule that trips up the most claims. CPT codes 96360, 96365, 96374, 96409, and 96413 are all defined as “initial” service codes, and Medicare rules are explicit that only one initial service code may be reported per patient encounter, with limited exceptions.
The hierarchy that determines which service becomes the initial code, when multiple types of drug administration happen in the same visit, generally runs infusion first, then push, then straightforward injection.
In practical terms, if a patient receives an IV infusion and also gets an IV push of a different drug during the same visit, the infusion takes the initial code position, and the push gets billed as a secondary or sequential service using the appropriate add-on code rather than its own standalone initial code.
One scope note: CPT directs facilities to apply this hierarchy mechanically, while physician offices select the initial code based on the primary reason for the encounter, which usually produces the same answer but not always. In a hospital outpatient department, the facility bills the administration codes and the physician reports only any separately supported E/M, so confirm the place of service before deciding who bills what.
When You Can Bill Two Initial Codes in One Encounter
There’s a specific, narrow exception to the one-initial-code rule.
If it’s medically reasonable and necessary for drug or substance administrations to occur at separate intravenous access sites, and this necessity is documented, you can report two different initial service codes for the same encounter.
To do this correctly, you need to append the appropriate NCCI procedure-to-procedure associated modifier, most commonly modifier 59, to the second initial code to show it represents a genuinely separate and distinct service rather than a duplicate billing of the same encounter.
Without that modifier and without documentation supporting the rationale for a separate access site, a second initial code on the same date will simply be denied by the payer’s system, since the default assumption is that only one initial service applies per visit.
Neurology Scenarios Involving the Hierarchy
- A migraine patient receives an infusion of one medication, followed by an IV push of an anti-nausea medication through the same access; the infusion is the initial code, and the push bills as add-on code 96375 (each additional sequential intravenous push of a new drug). A repeat push of the same drug within the visit uses 96376 instead, which is reportable only by facilities and only when at least 30 minutes separate the pushes.
- An MS patient receives scheduled infusion therapy and also needs a same-day IV push for an unrelated acute symptom, requiring careful documentation to justify billing both appropriately. The patient receives hydration alongside a therapeutic infusion, where the hydration typically doesn’t get billed separately unless it meets its own specific duration and medical necessity requirements
- Two different infusions are given through separate IV access sites for documented medical reasons, requiring a modifier 59 on the second initial code.
- A double-lumen catheter is used to infuse two different substances, which still counts as only one intravenous access site, meaning only one initial infusion code applies despite the two separate lumens.
Same-Day E/M Visits With Infusion Therapy
Billing an E/M visit on the same day as infusion therapy is common in neurology, particularly for migraine infusion patients and MS patients receiving disease-modifying therapy infusions.
Still, it requires careful documentation to support separate billing.
There’s a general presumption built into payer policy that an E/M service on the same day as an infusion or injection is part of that procedure, unless the provider clearly identifies the E/M as a significant, separately identifiable service in its own right.
When that separate identifiability genuinely exists, for example, the physician evaluates a new or changed symptom, adjusts the treatment plan, or addresses a concern unrelated to the reason for the infusion itself, modifier 25 gets appended to the E/M code.
Without clear documentation showing the E/M stood on its own clinically, the visit is bundled with the infusion service and isn’t separately reimbursed.
One category worth calling out specifically for neurology: CPT 99211, the lowest-level established patient E/M code, generally isn’t reimbursed when billed alongside an infusion or injection service, with or without modifier 25 attached, since this minimal-level code doesn’t meet the bar for a “significant” separately identifiable service under most payer policies.
When MS Biologics Bill 96413 Instead of 96365
Not every neurology infusion belongs in the 96365 family. CPT reserves a separate code set, 96413 for the first hour and 96415 for each additional hour, for chemotherapy and other highly complex drug or biologic agent administration, and Medicare guidance extends those codes to certain monoclonal antibodies and biologic response modifiers.
That definition covers several of the highest-cost infusions a neurology practice runs. Ocrelizumab, natalizumab, rituximab when used off-label for MS, and similar monoclonal antibodies are recognized by many payers under the complex biologic administration codes, because the monitoring burden and reaction risk exceed what the therapeutic infusion codes assume. Other payers have not adopted that position and expect the same drugs billed under 96365 and 96366.
The practical consequence: the administration code for the same drug, same chair, same nurse can legitimately differ from payer to payer. Manufacturer coding guides for these agents say exactly this, listing 96413 and 96415 as primary with 96365 and 96366 as the fallback where a payer does not recognize the complex administration codes. Billing 96365 to a payer that recognizes 96413 quietly underpays every session, since the complex administration codes reimburse at a higher rate. Billing 96413 to a payer that does not recognize it for the drug produces a denial.
Build a payer-by-drug grid for every biologic on your infusion schedule, verify it against each payer’s drug administration policy annually, and treat any remittance where the paid administration code differs from the billed one as a signal to recheck the grid.
Documentation Requirements That Protect These Claims
Every infusion and injection claim needs a specific set of documented elements, and missing any one of them is a common, avoidable source of denial.
- The chart needs to show the start and stop times for each infusion; the medication name, dosage, and route of administration; the specific indication (therapeutic, prophylactic, or diagnostic); whether the infusion was initial, sequential, or concurrent; and the signature of the administering clinician.
- Start and stop times deserve special attention, since they directly determine code selection and unit counts.
- A vague note that just says “infusion given” without timestamps leaves the biller unable to correctly select between 96365 alone versus 96365 plus one or more units of 96366, and payers increasingly deny claims outright when these timestamps are missing, rather than assuming a default duration.
- The medication itself bills separately under the appropriate HCPCS J-code, matched to the actual dose administered.
- A mismatch between the administration code’s implied duration or volume and the J-code units billed is exactly the kind of pattern that automated payer review systems are built to catch, so keeping these two elements consistent across the claim matters as much as getting the administration code itself correct.
Single-dose vial drugs carry one more claim-level requirement. Since July 1, 2023, CMS requires the JZ modifier on the drug line whenever a single-dose container is used and no drug is discarded, and the JW modifier on a separate line reporting any discarded amount. Most neurology infusion drugs, including the MS monoclonals and IVIG products, ship in single-dose containers, so nearly every drug line leaving a neurology infusion suite now needs one of these two modifiers. Claims missing the required modifier are returned or denied, and a pattern of JW lines with large discarded amounts draws payer attention to your dose-rounding practices.
Diagnosis Codes Supporting Neurology Infusion Claims
- Chronic migraine and related headache disorder codes supporting infusion therapy for acute or preventive treatment.
- Multiple sclerosis codes reflecting the specific phenotype, supporting disease-modifying infusion therapy
- Myasthenia gravis and other neuromuscular junction disorders supporting immunoglobulin infusion therapy
- Chronic inflammatory demyelinating polyneuropathy supporting IVIG infusion
- Status migrainosus supporting acute infusion treatment in an office or infusion suite setting
- Neuromuscular disease codes supporting supportive infusion therapy alongside disease-modifying treatment
Common Mistakes in Neurology Infusion Billing
Billing Two Initial-Service Codes (96365) Without a Modifier
Billing two 96365 codes for the first hour of two different infusions on the same date, without appending a modifier and without documentation proving two separate IV access sites were medically necessary.
The Solution:
- Modifier 59 (or XE/XP): Append modifier 59 (Distinct Procedural Service) or the more specific XP (Separate Practitioner) or XU (Unusual Non-Overlapping Service) to the second initial infusion code to indicate a distinct access site.
- Documentation: Ensure the nurse’s note explicitly states why a second separate site was required (e.g., “incompatible drugs,” “second PIV placed in opposite arm due to first site infiltration”).
- Pre-bill edit: Program your claims scrubber to flag any claim with two 96365 codes that lack a modifier, forcing a review before submission.
Rounding Infusion Durations Incorrectly
Rounding total infusion time up or down out of habit (e.g., rounding 46 minutes up to 1 hour, or rounding 91 minutes down to 1.5 hours) rather than billing exactly what the start/stop timestamps show.
The Solution:
- Bill exactly to the timestamp: Calculate time based on “stop time minus start time” to the exact minute.
- Use the 31-minute rule for 96366: To bill an additional hour (96366), you must have at least 31 minutes beyond the first hour (e.g., 1 hour 31 minutes = bill 2 units; 1 hour 29 minutes = bill only 1 unit).
- Do not round up: 61 minutes = 96365 only. The additional 96366 unit does not begin until total time reaches 91 minutes. 60 minutes = 96365 only.
- Do not round down: if the chart says 92 minutes, bill 96365 plus one unit of 96366, since 32 minutes beyond the hour qualifies. Do not short-change yourself
Confusing Sequential (96367) vs. Concurrent (96368) Infusions
Billing a second drug as “sequential” (96367) when it was actually started before the first infusion finished. Conversely, billing concurrent (96368) when the second drug was started only after the first bag hung dry.
The Solution:
- Remember the “Tap” rule: If the second drug is started while the first is still dripping (i.e., they overlap even for 1 minute), it is Concurrent (96368).
- Sequential (96367) is only used when the second drug is started after the first drug’s container is completely empty and the line is flushed.
- Check the times: Cross-reference the start time of Drug B against the stop time of Drug A. If Drug B start time < Drug A stop time → 96368. If Drug B start time ≥ Drug A stop time → 96367.
- Note: 96368 is an add-on code and is always billed in addition to the primary initial service (96365).
Billing Hydration Fluids (96360/96361) as a Therapeutic Infusion
Using hydration codes (96360 for first hour, 96361 for each additional hour) for IV fluids that are only being used to “keep the vein open” (KVO) before, during, or after a therapeutic drug infusion.
The Solution:
- Hydration is a primary service: 96360/96361 can only be billed if the sole purpose of the fluid is to treat or prevent dehydration (e.g., for a patient with vomiting/diarrhea) and it is not a carrier for a drug.
- Duration floor: hydration under 31 minutes is never separately billable, even when it is the only service. 96360 requires 31 minutes to one hour, and 96361 follows the same greater-than-30-minutes logic for additional units.
- KVO = Not billable: If the fluid is running at a TKO/KVO rate (e.g., 10-20 mL/hr) just to maintain access between drug infusions, do not bill for hydration. This time is considered part of the therapeutic infusion service.
- Carrier fluids = Not billable: If the fluid is the diluent for a piggyback medication (e.g., 50 mL NS with Keppra), that time is bundled into the therapeutic infusion code.
- Rule of thumb: If a drug is attached to the line at any point during that hour, you cannot bill hydration for that hour. Use only 96365-96368 for therapeutic infusions.
Frequently Asked Questions
Can we bill both an infusion code and an injection code on the same day for a neurology patient?
Yes, this is common and generally appropriate as long as the hierarchy rules are followed correctly: the infusion typically becomes the initial code, while the injection is billed as a secondary service using the appropriate code, or, in some cases, as its own separately justified service with supporting documentation. The key is making sure only one true “initial” service code is billed unless a documented separate access site justifies reporting two.
What happens if our documentation is missing exact start and stop times for an infusion?
This is one of the most common reasons infusion claims get denied outright, since CMS requires documented start and stop times to determine both the correct base code and any additional time-based units. Without this documentation, many payers will deny the claim rather than assume a default duration, so building a hard stop into your charting workflow that requires these timestamps before a note can be closed out prevents a significant share of avoidable denials.
Is modifier 25 always required when billing an E/M visit with an infusion on the same day?
Modifier 25 is required whenever the E/M service is billed in addition to the infusion or injection and needs to be distinguished as a separately identifiable service, since payer policy generally presumes the E/M is otherwise bundled into the procedure. If the visit truly involved only the infusion itself with no separate clinical decision-making beyond that procedure, no separate E/M should be billed at all, with or without the modifier.
How is a sequential infusion different from a concurrent infusion for billing purposes?
A sequential infusion means one drug’s administration fully ends before the next one begins through the same IV access, documented with a clear stop time for the first and start time for the second, billed under add-on code 96367. A concurrent infusion means two drugs are running through the same access at the same time, billed under add-on code 96368, which is reported only once per encounter, regardless of how many drugs run together or for how long.
What’s the biggest revenue risk specific to neurology infusion billing?
Beyond the general hierarchy and timing errors common to all specialties, neurology infusion billing presents specific risks related to prior authorization expiration for high-cost disease-modifying infusions, since these authorizations often have narrow validity windows. A scheduling delay that pushes an infusion past its authorization expiration date typically results in an unrecoverable denial, making proactive authorization tracking just as important as correct CPT coding for protecting infusion revenue in a neurology practice.
Final Thoughts
Infusion and injection billing in the 96365 series rewards practices that build discipline into their charting and pre-bill review process.
The hierarchy rule, the thirty-minute threshold for additional units, and the sequential-versus-concurrent distinction aren’t arbitrary technicalities; they reflect real differences in how these treatments are actually delivered, and getting them right protects both your revenue and your compliance standing.
For neurology practices running regular migraine, MS, or neuromuscular infusion programs, this is a coding area worth auditing regularly rather than treating as a one-time setup task.
Infusion billing errors tend to compound quietly across a busy neurology infusion schedule. By the time they show up in your AR reports, months of revenue may already be affected. UControl Billing specializes in neurology infusion and injection billing, from hierarchy compliance to prior authorization tracking for high-cost disease-modifying therapies. Contact us today for a free audit of your infusion billing workflow.
———————————–
Focus keyword:
Slug:
Meta title:
Meta description:
——————————-
